α-酮硫酰胺衍生物：一种用于研究磷酸甘油酸脱氢酶（PHGDH）的有前景的工具。
α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH).
作者信息
Ravez Séverine, Corbet Cyril, Spillier Quentin, Dutu Alice, Robin Anita D, Mullarky Edouard, Cantley Lewis C, Feron Olivier, Frédérick Raphaël
机构信息
Medicinal Chemistry Research Group (CMFA), Louvain Drug Research Institute (LDRI), Université Catholique de Louvain , 73 avenue Mounier, B-1200 Brussels, Belgium.
Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain , B-1200 Brussels, Belgium.
出版信息
J Med Chem. 2017 Feb 23;60(4):1591-1597. doi: 10.1021/acs.jmedchem.6b01166. Epub 2017 Jan 27.
Abstract
Given the putative role of PHGDH in cancer, development of inhibitors is required to explore its function. In this context, we established and validated a straightforward enzymatic assay suitable for high-throughput screening and we identified inhibitors with similar chemical scaffolds. Through a convergent pharmacophore approach, we synthesized α-ketothioamides that exhibit interesting in vitro PHGDH inhibition and encouraging cellular results. These novel probes may be used to understand the emerging biology of this metabolic target.
摘要
鉴于磷酸甘油酸脱氢酶（PHGDH）在癌症中的假定作用，需要开发抑制剂来探索其功能。在此背景下，我们建立并验证了一种适用于高通量筛选的直接酶促测定法，并鉴定出具有相似化学骨架的抑制剂。通过收敛药效团方法，我们合成了α-酮硫代酰胺，其在体外表现出有趣的PHGDH抑制作用和令人鼓舞的细胞实验结果。这些新型探针可用于了解这个代谢靶点的新兴生物学特性。
相似文献
1
α-Ketothioamide Derivatives: A Promising Tool to Interrogate Phosphoglycerate Dehydrogenase (PHGDH).α-酮硫酰胺衍生物：一种用于研究磷酸甘油酸脱氢酶（PHGDH）的有前景的工具。
J Med Chem. 2017 Feb 23;60(4):1591-1597. doi: 10.1021/acs.jmedchem.6b01166. Epub 2017 Jan 27.
2
A retrospective overview of PHGDH and its inhibitors for regulating cancer metabolism.回顾性概述 PHGDH 及其抑制剂在调节癌症代谢中的作用。
Eur J Med Chem. 2021 May 5;217:113379. doi: 10.1016/j.ejmech.2021.113379. Epub 2021 Mar 16.
3
Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review 2015-2020.磷酸甘油酸脱氢酶（PHGDH）抑制剂：2015-2020 年全面综述。
Expert Opin Ther Pat. 2021 Jul;31(7):597-608. doi: 10.1080/13543776.2021.1890028. Epub 2021 Mar 29.
4
Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.理性设计选择性别构抑制剂 PHGDH 和丝氨酸合成及其抗肿瘤活性。
Cell Chem Biol. 2017 Jan 19;24(1):55-65. doi: 10.1016/j.chembiol.2016.11.013. Epub 2016 Dec 29.
5
Challenges and Opportunities in the Development of Serine Synthetic Pathway Inhibitors for Cancer Therapy.用于癌症治疗的丝氨酸合成途径抑制剂开发中的挑战与机遇
J Med Chem. 2017 Feb 23;60(4):1227-1237. doi: 10.1021/acs.jmedchem.6b01167. Epub 2016 Dec 22.
6
Discovery and optimization of piperazine-1-thiourea-based human phosphoglycerate dehydrogenase inhibitors.基于哌嗪-1-硫脲的人磷酸甘油酸脱氢酶抑制剂的发现和优化。
Bioorg Med Chem. 2018 May 1;26(8):1727-1739. doi: 10.1016/j.bmc.2018.02.016. Epub 2018 Feb 27.
7
Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase.氮杂环丁酮 E 通过靶向 3-磷酸甘油酸脱氢酶抑制癌细胞生长。
Bioorg Chem. 2019 Jun;87:16-22. doi: 10.1016/j.bioorg.2019.02.037. Epub 2019 Feb 23.
8
Inhibition of 3-phosphoglycerate dehydrogenase (PHGDH) by indole amides abrogates de novo serine synthesis in cancer cells.吲哚酰胺抑制 3-磷酸甘油酸脱氢酶（PHGDH）可消除癌细胞中的从头丝氨酸合成。
Bioorg Med Chem Lett. 2019 Sep 1;29(17):2503-2510. doi: 10.1016/j.bmcl.2019.07.011. Epub 2019 Jul 6.
9
Unravelling the Allosteric Targeting of PHGDH at the ACT-Binding Domain with a Photoactivatable Diazirine Probe and Mass Spectrometry Experiments.用光活化重氮化合物探针和质谱实验解析 PHGDH 在 ACT 结合域的别构靶向。
Molecules. 2021 Jan 18;26(2):477. doi: 10.3390/molecules26020477.
10
Discovery of novel inhibitors of human phosphoglycerate dehydrogenase by activity-directed combinatorial chemical synthesis strategy.通过基于活性的组合化学合成策略发现新型人磷酸甘油酸脱氢酶抑制剂。
Bioorg Chem. 2021 Oct;115:105159. doi: 10.1016/j.bioorg.2021.105159. Epub 2021 Jul 8.
引用本文的文献
1
PHGDH inhibition and FOXO3 modulation drives PUMA-dependent apoptosis in osteosarcoma.磷酸甘油酸脱氢酶抑制和叉头框蛋白O3调节驱动骨肉瘤中依赖p53上调凋亡调节因子的细胞凋亡。
Cell Death Dis. 2025 Feb 12;16(1):89. doi: 10.1038/s41419-025-07378-6.
2
Thioamides in medicinal chemistry and as small molecule therapeutic agents.硫代酰胺在药物化学中以及作为小分子治疗剂。
Eur J Med Chem. 2024 Nov 5;277:116732. doi: 10.1016/j.ejmech.2024.116732. Epub 2024 Aug 5.
3
Targeting allosteric regulation of cancer metabolism.靶向癌症代谢的变构调节。
Nat Chem Biol. 2022 May;18(5):441-450. doi: 10.1038/s41589-022-00997-6. Epub 2022 Apr 28.
4
Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling.通过化学蛋白质组学和表型分析鉴定一种新型磷酸甘油酸脱氢酶共价抑制剂
Acta Pharm Sin B. 2022 Jan;12(1):246-261. doi: 10.1016/j.apsb.2021.06.008. Epub 2021 Jun 16.
5
Biophysical and biochemical properties of PHGDH revealed by studies on PHGDH inhibitors.通过对 PHGDH 抑制剂的研究揭示了 PHGDH 的生物物理和生化特性。
Cell Mol Life Sci. 2021 Dec 31;79(1):27. doi: 10.1007/s00018-021-04022-2.
6
Targeting cancer metabolism in the era of precision oncology.精准肿瘤学时代的肿瘤代谢靶向治疗。
Nat Rev Drug Discov. 2022 Feb;21(2):141-162. doi: 10.1038/s41573-021-00339-6. Epub 2021 Dec 3.
7
Dimerization of PHGDH via the catalytic unit is essential for its enzymatic function.通过催化单元使磷酸甘油酸脱氢酶二聚化对其酶功能至关重要。
J Biol Chem. 2021 Jan-Jun;296:100572. doi: 10.1016/j.jbc.2021.100572. Epub 2021 Mar 19.
8
3-Phosphoglycerate dehydrogenase: a potential target for cancer treatment.3-磷酸甘油酸脱氢酶：癌症治疗的潜在靶点。
Cell Oncol (Dordr). 2021 Jun;44(3):541-556. doi: 10.1007/s13402-021-00599-9. Epub 2021 Mar 18.
9
The ins and outs of serine and glycine metabolism in cancer.癌症中丝氨酸和甘氨酸代谢的来龙去脉。
Nat Metab. 2021 Feb;3(2):131-141. doi: 10.1038/s42255-020-00329-9. Epub 2021 Jan 28.
10
Unravelling the Allosteric Targeting of PHGDH at the ACT-Binding Domain with a Photoactivatable Diazirine Probe and Mass Spectrometry Experiments.用光活化重氮化合物探针和质谱实验解析 PHGDH 在 ACT 结合域的别构靶向。
Molecules. 2021 Jan 18;26(2):477. doi: 10.3390/molecules26020477.
本文引用的文献
1
RETRACTED: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.撤回：PHGDH 表达对于线粒体氧化还原稳态、乳腺癌干细胞维持和肺转移是必需的。
Cancer Res. 2016 Aug 1;76(15):4430-42. doi: 10.1158/0008-5472.CAN-16-0530. Epub 2016 Jun 8.
2
Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype.丝氨酸/甘氨酸代谢相关蛋白的表达因甲状腺癌亚型而异。
J Transl Med. 2016 Jun 8;14(1):168. doi: 10.1186/s12967-016-0915-8.
3
Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer.磷酸甘油酸脱氢酶（PHGDH）在结直肠癌中的表达增加及其预后意义
Transl Oncol. 2016 Jun;9(3):191-6. doi: 10.1016/j.tranon.2016.03.006. Epub 2016 May 10.
4
An improved model for fragment-based lead generation at AstraZeneca.阿斯利康基于片段的先导化合物发现的改进模型。
Drug Discov Today. 2016 Aug;21(8):1272-83. doi: 10.1016/j.drudis.2016.04.023. Epub 2016 May 11.
5
A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate.一种磷酸甘油酸脱氢酶（PHGDH）抑制剂揭示了丝氨酸合成与一碳单位命运的协调关系。
Nat Chem Biol. 2016 Jun;12(6):452-8. doi: 10.1038/nchembio.2070. Epub 2016 Apr 25.
6
Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers.鉴定一种3-磷酸甘油酸脱氢酶小分子抑制剂以靶向癌症中的丝氨酸生物合成。
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1778-83. doi: 10.1073/pnas.1521548113. Epub 2016 Feb 1.
7
Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth.降低丝氨酸的可利用性可补充谷氨酰胺代谢抑制作用，以阻断白血病细胞的生长。
Oncotarget. 2016 Jan 12;7(2):1765-76. doi: 10.18632/oncotarget.6426.
8
NRF2 regulates serine biosynthesis in non-small cell lung cancer.NRF2调节非小细胞肺癌中的丝氨酸生物合成。
Nat Genet. 2015 Dec;47(12):1475-81. doi: 10.1038/ng.3421. Epub 2015 Oct 19.
9
Human phosphoglycerate dehydrogenase produces the oncometabolite D-2-hydroxyglutarate.人类磷酸甘油酸脱氢酶产生致癌代谢物D-2-羟基戊二酸。
ACS Chem Biol. 2015 Feb 20;10(2):510-6. doi: 10.1021/cb500683c. Epub 2014 Nov 18.
10
Serine and glycine metabolism in cancer.癌症中的丝氨酸和甘氨酸代谢
Trends Biochem Sci. 2014 Apr;39(4):191-8. doi: 10.1016/j.tibs.2014.02.004. Epub 2014 Mar 20.
Zotero 插件